OpenVSafe by OpenVAERS
Search V-safe

ZCL-14667-89111

5 vaccinations 8 coded responses 61 check-ins 8 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
282 / NC
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Registered in v-safe
  2. 2020-12-31
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-31
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-02
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-21
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-21
    Health check-in — day 0, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activities
    Free text: Significant and visible enlargement of the axillary lymph nodes on the side of the injection, mild tenderness on the other side.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy, Tenderness — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Axillary lymph nodes on the side of the injection visibly enlarged and tender but improving.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Lymphadenopathy — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Axillary lymph nodes on the side of the injection are enlarged but going down. Dizziness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-01-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-11
    Survey response — day 21, dose 2
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Persistent headache, at times moderate to severe.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-22
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-25
    Dose 3 — Pfizer-BioNTech
  29. 2021-09-30
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Headache
    Free text: Axillary lymph nodes are swollen
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Axillary lymph nodes are enlarged on the side of the vaccine
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-02
    Health check-in — day 7, dose 3
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  32. 2021-10-09
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-16
    Survey response — day 21, dose 3
    MedDRA: Abdominal pain upper, Nausea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea, stomach cramps
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-23
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-10-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-06
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  37. 2021-12-25
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-03-26
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-05-16
    Dose 4 — Moderna
  40. 2022-05-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  41. 2022-05-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  42. 2022-05-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  43. 2022-05-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  44. 2022-05-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  45. 2022-05-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache
    Adult check-in
  46. 2022-05-23
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  47. 2022-05-30
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-06-06
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  49. 2022-06-13
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-06-20
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-06-29
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-08-15
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-10-07
    Dose 5 — Moderna
    Co-administered: Flu
  54. 2022-10-07
    Health check-in — day 0, dose 5
    Feeling: Good · None
    Adult check-in
  55. 2022-10-08
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Nausea
    Adult check-in
  56. 2022-10-09
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  57. 2022-10-10
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  58. 2022-10-11
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  59. 2022-10-12
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  60. 2022-10-13
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  61. 2022-10-14
    Health check-in — day 7, dose 5
    Feeling: Good · Site: Itching · None
    Adult check-in
  62. 2022-10-21
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  63. 2022-10-28
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  64. 2022-11-04
    Survey response — day 28, dose 5
    MedDRA: Conjunctivitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Conjunctivitis both eyes
    MedDRA releases: 2024-11 · check-in free text available
  65. 2022-11-04
    Report sent to call center — day 28, dose 5
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  66. 2022-11-07
  67. 2022-11-11
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  68. 2022-11-18
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  69. 2023-01-06
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  70. 2023-04-07
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Pfizer-BioNTech
22021-01-21Pfizer-BioNTech
32021-09-25Pfizer-BioNTech No
42022-05-16Moderna No
52022-10-07Moderna Flu

Call center

ReportedOutcomeVAERS-related outcome
2021-01-02 priority 2/3
2022-11-04 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-23

Systemic reaction (other): Significant and visible enlargement of the axillary lymph nodes on the side of the injection, mild tenderness on the other side.

2021-01-24

Systemic reaction (other): Axillary lymph nodes on the side of the injection visibly enlarged and tender but improving.

2021-01-25

Systemic reaction (other): Axillary lymph nodes on the side of the injection are enlarged but going down. Dizziness.

Release 4 — day 21, dose 2

2021-02-11

Symptoms: Persistent headache, at times moderate to severe.

Release 9 — days 1–6 daily, dose 3

2021-09-30

Systemic reaction (other): Axillary lymph nodes are swollen

2021-10-01

Systemic reaction (other): Axillary lymph nodes are enlarged on the side of the vaccine

Release 10 — day 21, dose 3

2021-10-16

Symptoms: Nausea, stomach cramps

Release 12 — day 28, dose 5

2022-11-04

Symptoms: Conjunctivitis both eyes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper · · ✓
SDConjunctivitis · · ✓
SDHeadache ✓ ✓ ✓
SDNausea · · ✓
SRODizziness ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROTenderness ○ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release